OTU MEDICAL INC. PARTNERS WITH KARL STORZ SE & Co. KG FOR CYSTOSCOPES WORLDWIDE
The collaboration brings together OTU Medical Inc’s platform technology in cystoscopy and KARL STORZ SE & Co. KG (KARL STORZ) ’s worldwide distribution capabilities. The partnership will provide KARL STORZ with OTU Medical Inc. (“OTU”)’s single use cystoscopes worldwide.
“We are excited about the possibilities of this partnership. This is an excellent opportunity for us to expand our “Your Patient. Your Choice.” hybrid solution by now offering Reusable & Single-Use Endoscopes also to Flexible Cystoscopy. Doing so, we are delighted to enable our customers with maximum flexibility and the power to choose between Reusable & Single-Use Endoscopes according to their individual medical needs,” highlights Michael Koch, Senior Director Lower Endoscopy within Global Marketing at KARL STORZ.
“We are very much looking forward to partnering with KARL STORZ to market and expand our single use cystoscopes worldwide and to also pushing forward potential collaborations for other specialties in the field of endoscopy besides Urology in the future,” said Xibo Wei, Co-Founder and Chief Executive Officer of OTU. “This partnership demonstrates how industry leaders can leverage each other strengths to address the changing needs of the healthcare industry to deliver best performing and cost-effective solutions”
About OTU Medical Inc.
Based in California and founded in 2017, OTU Medical Inc., together with its sister company Ningbo Wise OptoMech Technology Corporation, is a fully vertically integrated endoscope company that develops, manufactures and markets directly and indirectly innovative and cost-effective one-time use endoscopes worldwide. It has developed and approved products in the market in urology, bronchoscopy, GI and others. For additional information, please visit: www.otumed.com
About KARL STORZ SE & Co. KG
The medical technology company KARL STORZ was founded in 1945 in Tuttlingen, Germany, and is an international leader in the world of endoscopy. Now in its third generation, the family-owned company employs 8,800 people in more than 40 countries worldwide. The company portfolio includes more than 15,000 products for human and veterinary medicine. KARL STORZ stands for visionary design, precision craftsmanship and clinical effectiveness. Preliminary sales for the fiscal year 2022 amounted to 2.06 billion euros. Production sites are located in Germany, the USA, Switzerland and Estonia. For more information, please visit: www.karlstorz.com